about
Dietary advanced glycation end products and their role in health and diseaseTau-targeted treatment strategies in Alzheimer's diseaseOptimization of time-course experiments for kinetic model discriminationAnimal models for Alzheimer's disease and frontotemporal dementia: a perspectiveYeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formationTau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.Structural studies on a mitochondrial glyoxalase II.Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.Does chronic glycolysis accelerate aging? Could this explain how dietary restriction works?wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early deathMethylglyoxal, the dark side of glycolysisModes of Aβ toxicity in Alzheimer's disease.Alzheimer's disease models and functional genomics-How many needles are there in the haystack?Human glyoxalase II contains an Fe(II)Zn(II) center but is active as a mononuclear Zn(II) enzymeGenetics, transcriptomics, and proteomics of Alzheimer's diseaseDo axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?Would carnosine or a carnivorous diet help suppress aging and associated pathologies?Aldehyde metabolism in the cardiovascular system.A decade of tau transgenic animal models and beyond.Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.What Renders TAU ToxicAn update on the toxicity of Abeta in Alzheimer's disease.Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.Arabidopsis thaliana GLX2-1 contains a dinuclear metal binding site, but is not a glyoxalase 2.Copy number variation influences gene expression and metabolic traits in mice.Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease.Glycation research in amino acids: a place to call home.Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.The role of vitamin D in Alzheimer's disease: possible genetic and cell signaling mechanisms.Measurement of glyoxalase gene expression.Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.Glyoxalase Centennial conference: introduction, history of research on the glyoxalase system and future prospects.Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation.Distinct classes of glyoxalase I: metal specificity of the Yersinia pestis, Pseudomonas aeruginosa and Neisseria meningitidis enzymes.The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's diseaseTranscriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory responseTumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.Proteomic analysis of proteins expressing in regions of rat brain by a combination of SDS-PAGE with nano-liquid chromatography-quadrupole-time of flight tandem mass spectrometry.
P2860
Q26801247-DAE4C7A5-8DF6-49F5-B6A9-424436909956Q27023429-0DFE2A3F-72E3-4DC0-AE89-EA6308A48C10Q28481387-D9F81E1D-3B3B-4AAB-A8DE-8B67DBF3303EQ28749702-6921A019-7495-4AF5-910A-0C3FB19E06B0Q33261536-70285F7B-1D9F-4C0C-AD6F-0942C5A2ED83Q33984004-91127124-165E-4899-9707-DC1EFB186C2CQ34256620-4A5446B1-F769-4770-9DC6-F7700C007CD8Q34293884-B32EF7EC-6C92-4C81-AE3D-EE8114E9C853Q34534524-26972203-F768-4671-BBEF-10BA94E9DB6CQ34542350-8310EED1-962C-4909-82CE-4F2603B63E32Q35056697-2D835322-1BBF-40FD-AB90-771150723F1FQ35063131-7F15A5BD-FE71-4C80-98E6-C1568A6010F8Q35235869-FFAB552A-7C71-49B3-AEE6-ABB648FDDEEAQ36193841-6932CD35-B3C0-433C-ADB3-DCA05B463494Q36233220-7BDDF911-B140-41F2-BD62-438F1477061FQ36466472-DDC3F009-8712-42E7-B1DB-769F0106B417Q36513243-544EA1BB-0AEF-4B66-80C7-CFFAF1246DFEQ36521008-7A4D4D69-3345-4855-A0F6-871E08408162Q36716474-701268BB-61E7-40F4-924E-DE96AED04AEDQ36817223-4CF05A2C-95AF-4920-990C-D27561527F82Q36824440-35C21610-2463-45D2-8912-7A9AEE4C372DQ36914658-7FF91A26-D5A7-41B7-8A44-FE996C6CC41FQ37106932-EE74DFF2-0BD8-4FA9-B194-600F5F53B4FCQ37112969-3F4475A4-33AB-46B1-B26F-2B6312B16519Q37181170-362FB4DD-0CD0-49E4-B12B-B42E8E084CC9Q37378108-9131FC64-7E10-4DAB-90C6-182B0C1A500FQ37462790-88BCF236-3F07-4781-A7E0-B17DB53BD7CBQ37803550-21B4E046-5E88-4E1F-8A2D-F2BBDB0BB52CQ38018504-0E20E056-DB73-4C2B-B8D6-DF8D38E10F4DQ38074422-6A3FA2D9-3C9D-4715-BC7A-B89B6A492838Q38197353-B6102380-037A-46C9-91A8-F8016E593E68Q38311623-8BC31938-4C4B-4DC2-BBB9-419482F38BB0Q38394355-9FE05EF4-014F-4B07-8766-88C7DE4C3D47Q39227732-97230F27-FFD3-4D8B-80E4-C0929C9C72D2Q39314131-026DC4DC-400F-4D6D-8F2C-FA5E671FD3E1Q41461864-92B55C4C-5F31-4515-845C-AC7AA15C5474Q41852765-40E4DF5A-7010-4B1A-B5E3-F36478782086Q42060830-A251498B-33DD-4E7F-9BD2-3FA28D1C2FC5Q42155901-2872C486-AFC3-4D96-947D-ACA0C92E0546Q42160594-6A00F49A-B570-4080-8D64-7334A54B75AE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Role for glyoxalase I in Alzheimer's disease.
@ast
Role for glyoxalase I in Alzheimer's disease.
@en
Role for glyoxalase I in Alzheimer's disease.
@nl
type
label
Role for glyoxalase I in Alzheimer's disease.
@ast
Role for glyoxalase I in Alzheimer's disease.
@en
Role for glyoxalase I in Alzheimer's disease.
@nl
prefLabel
Role for glyoxalase I in Alzheimer's disease.
@ast
Role for glyoxalase I in Alzheimer's disease.
@en
Role for glyoxalase I in Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Role for glyoxalase I in Alzheimer's disease
@en
P2093
Andreas Papassotiropoulos
Björn Kuhla
Evgeny I Rogaev
Frederic Hoerndli
Gerald Münch
M Axel Wollmer
P2860
P304
P356
10.1073/PNAS.0402338101
P407
P577
2004-05-05T00:00:00Z